Top Suppliers:I want be here

1242443-29-3

1242443-29-3 structure
1242443-29-3 structure
  • Name: VU0364289
  • Chemical Name: vu0364289
  • CAS Number: 1242443-29-3
  • Molecular Formula: C20H21N3O2
  • Molecular Weight: 335.40000
  • Catalog: Signaling Pathways GPCR/G Protein mGluR
  • Create Date: 2018-06-03 08:48:00
  • Modify Date: 2024-03-07 18:29:56
  • VU0364289 is a highly selective mGlu5 positive allosteric modulator (PAM) (binds to the MPEP (HY-14609A) site), with an EC50 of 1.6 µM. VU0364289 can reverse amphetamine-induced hyperlocomotion in a dose-dependent manner, which can be used for schizophrenia and other psychiatric research[1][2][3].

Name vu0364289
Description VU0364289 is a highly selective mGlu5 positive allosteric modulator (PAM) (binds to the MPEP (HY-14609A) site), with an EC50 of 1.6 µM. VU0364289 can reverse amphetamine-induced hyperlocomotion in a dose-dependent manner, which can be used for schizophrenia and other psychiatric research[1][2][3].
Related Catalog
Target

mGlu5:1.6 μM (EC50)

In Vivo VU0364289 (10, 30, 56.6, 100 mg/kg ; i.p.; once) reverse amphetamine-induced hyperlocomotion in a dose-dependent manner, and (56.6, 100 mg/kg) shows significantly fewer ambulations[1]. VU0364289 (10 mg/kg; i.p.; once) is rapidly and significantly absorbed in rats, and shows excellent central nervous system penetration[1]. Animal Model: Adult male Sprague-Dawley rats (250-275 g)[1]. Dosage: 10, 30, 56.6, 100 mg/kg Administration: Intraperitoneal injection; once. Result: Showed activity of reversing the hyperlocomotion induced by amphetamine, and can also significantly fewer ambulations in rats when dose up to 56.6 mg/kg. Animal Model: Adult male Sprague-Dawley rats (250-275 g)[1]. Dosage: 10 mg/kg Administration: Intraperitoneal injection; once. Result: 1.19Pharmacokinetic Parameters of VU0364289 in male Sprague-Dawley rats[1]. Tmax (h) Cmax (ng/mL) Plasma protein binding Rat Fu (free fraction) IP (10 mg/kg) 0.25 1280 94% (h); 90% (r) 0.10
References

[1]. Gregory KJ, et al. N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement. J Pharmacol Exp Ther. 2013 Nov;347(2):438-57.

[2]. Ya Zhou, et al. Discovery of N-Aryl Piperazines as Selective mGluR5Potentiators with Improved In Vivo Utility. ACS medicinal chemistry letters, 2010, 1(8): 433-438.

[3]. Psychosis Models[M]//Melatonin, Neuroprotective Agents and Antidepressant Therapy. Springer, New Delhi, 2016: 731-750.

Molecular Formula C20H21N3O2
Molecular Weight 335.40000
Exact Mass 335.16300
PSA 56.57000
LogP 2.42658
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.